
PULMO/MERCURIUS ampoules
Pack size:10 x 1 ml Dosage form:ampoules
Pulmo/Mercurius, liquid dilution for injection. Indications: According to anthroposophical understanding of man and nature. These include: Stimulating the reorganization of the lung organ during inflammatory processes, particularly in phases of increased secretion and tissue proliferation, e.g. bronchitis, pneumonia (bronchopneumonia) and subsequent conditions such as pulmonary distension (emphysema).
For risks and side effects, read the package insert and ask your doctor or pharmacist.
INSTRUCTIONS FOR USE: INFORMATION FOR THE USER
Pulmo/Mercurius, liquid dilution for injection
Composition:
1 ampoule contains: Mercurius vivus Dil. D14 aquos. 0.1 g, Pulmo bovis Gl Dil. D5 0.1 g (HAB, Vs. 41a). Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.
Indications:
According to anthroposophical understanding of man and nature. These include: stimulating the reorganization of the lung organ during inflammatory processes, particularly during phases of increased secretion and tissue proliferation, e.g. bronchitis, pneumonia (bronchopneumonia) and subsequent conditions such as pulmonary distension (emphysema).
Contraindications:
This medicine should not be used in cases of hypersensitivity to the donor animal protein.
Precautions for use and warnings:
There is no adequately documented experience with the use of this medicine in children. It should therefore not be used in children under 12 years of age.
Dosage and method of administration:
Unless otherwise prescribed, inject 1 ml subcutaneously twice a week to once a day.
Side effects:
None known.
Contents:
10 x 1 ml
Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden
This package leaflet was last revised in January 2025.
Source: Information from the Wala catalogue
as of: 05/2025
Areas of application: According to anthroposophical understanding of man and nature. These include: Stimulating the reorganization of the lung organ during inflammatory processes, especially during phases of increased secretion and tissue proliferation, e.g., bronchitis, pneumonia (bronchopneumonia), and subsequent conditions such as pulmonary emphysema.